XtalPi Holdings Limited ("XtalPi," HKEX: 2228), an AI- and robotics-driven drug and materials discovery company, today announced the nomination of its first internally developed small interfering RNA ...

MitoCareX expands its internal bioinformatics expertise to broaden the analysis of disease biology within its computational drug-discovery activities Ness Ziona, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) ...

Shahebaz Pathan, a certified Project Management Professional (PMP) with over 12 years of experience in enterprise syst ...

Jeremy Rifkin, one of the World’s Leading Public Intellectuals, Argues in his New Book ‘Rescuing the Future’ that the People’s AI is on a Deep Existential Curve and Likely to Surpass the Corporate AI ...

Google has made its AI model Gemini 4 Argon available globally for developers and enterprises through API access. This launch ...

The Board of Trustees received an update on initiatives underway as part of implementation of OHIO’s Dynamic Strategy during ...

OpenAI gives $5 million to the Simons Foundation as part of a $15 million push to help mathematicians verify and build on ...

Ethereum's Glamsterdam upgrade could change fees, throughput, and wallet behavior on iPhone and Mac as Sepolia testing began ...

Leading computational chemistry expert to advise MitoCareX as it expands its in silico drug-discovery capabilities Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc.

The NSF is launching Quantum+X, new research challenges and workforce programs focused on quantum technology and U.S.

AstraZeneca has entered into a strategic drug discovery collaboration and licensing agreement with insitro to use artificial intelligence to identify new drug targets and develop potential treatments ...

Bittensor pays for AI work, while Bitcoin's AI link runs through miners and AI agents. Which is the better buy for the AI ...